Beyond Air, Inc. Pre-Tax Income
Beyond Air, Inc. (XAIR) reported Pre-Tax Income of -$8.15 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2026-08-13
- Beyond Air, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-06-30 was -$8.15M.
- Beyond Air, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-03-31 was -$10.37M.
- Beyond Air, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-12-31 was -$7.63M.
- Beyond Air, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-09-30 was -$8.26M.
- Beyond Air, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2026 was -$34.33M.
- Beyond Air, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2025 was -$48.48M.
- Beyond Air, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2024 was -$64.30M.
- Beyond Air, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2023 was -$59.40M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$8.15M 10-Q · filed 2026-08-13 | -$18.52M derived: sum of 2 quarters · filed 2026-08-13 | -$26.15M derived: sum of 3 quarters · filed 2026-08-13 | -$34.41M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | -$10.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26 | -$18.00M derived: sum of 2 quarters · filed 2026-06-26 | -$26.26M derived: sum of 3 quarters · filed 2026-06-26 | -$34.33M 10-K · filed 2026-06-26 | |
| 2025-12-31 | -$7.63M 10-Q · filed 2026-02-13 | -$15.89M derived: sum of 2 quarters · filed 2026-02-13 | -$23.97M 10-Q · filed 2026-02-13 | -$32.03M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-09-30 | -$8.26M 10-Q · filed 2025-11-10 | -$16.34M 10-Q · filed 2025-11-10 | -$24.40M derived: sum of 3 quarters · filed 2026-08-13 | -$37.73M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | -$8.08M 10-Q · filed 2026-08-13 | -$16.14M derived: sum of 2 quarters · filed 2026-08-13 | -$29.47M derived: sum of 3 quarters · filed 2026-08-13 | -$43.50M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | -$8.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26 | -$21.40M derived: sum of 2 quarters · filed 2026-06-26 | -$35.42M derived: sum of 3 quarters · filed 2026-06-26 | -$48.48M 10-K · filed 2026-06-26 | |
| 2024-12-31 | -$13.33M 10-Q · filed 2026-02-13 | -$27.36M derived: sum of 2 quarters · filed 2026-02-13 | -$40.42M 10-Q · filed 2026-02-13 | -$54.97M derived: sum of 4 quarters · filed 2026-02-13 | |
| 2024-09-30 | -$14.03M 10-Q · filed 2025-11-10 | -$27.08M 10-Q · filed 2025-11-10 | -$41.64M derived: sum of 3 quarters · filed 2025-11-10 | -$58.90M derived: sum of 4 quarters · filed 2025-11-10 | |
| 2024-06-30 | -$13.05M 10-Q · filed 2025-08-12 | -$27.61M derived: sum of 2 quarters · filed 2025-08-12 | -$44.87M derived: sum of 3 quarters · filed 2025-08-12 | -$62.30M derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | -$14.56M derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-20 | -$31.81M derived: sum of 2 quarters · filed 2025-06-20 | -$49.24M derived: sum of 3 quarters · filed 2025-06-20 | -$64.30M 10-K · filed 2025-06-20 | |
| 2023-12-31 | -$17.26M 10-Q · filed 2025-02-10 | -$34.68M derived: sum of 2 quarters · filed 2025-02-10 | -$49.74M 10-Q · filed 2025-02-10 | ||
| 2023-09-30 | -$17.43M 10-Q · filed 2024-11-12 | -$32.48M 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | -$15.05M 10-Q · filed 2024-08-06 | ||||
| 2023-03-31 | -$59.40M 10-K · filed 2024-06-24 | ||||
| 2022-03-31 | -$44.06M 10-K · filed 2023-06-22 | ||||
| 2021-03-31 | -$22.88M 10-K · filed 2022-06-29 | -$22.87M 10-K · filed 2021-06-10 | |||
| 2020-03-31 | -$20.10M 10-K · filed 2021-06-10 | ||||
| 2019-03-31 | -$6.59M 10-K · filed 2020-06-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |